CSF placental growth factor – a novel candidate biomarker of frontotemporal dementia

OBJECTIVE: Diagnosis of frontotemporal dementia (FTD) is complicated by the overlap of clinical symptoms with other dementia disorders. Development of robust fluid biomarkers is critical to improve the diagnostic work‐up of FTD. METHODS: CSF concentrations of placental growth factor (PlGF) were meas...

Descripción completa

Detalles Bibliográficos
Autores principales: Hansson, Oskar, Santillo, Alexander F., Meeter, Lieke H., Nilsson, Karin, Landqvist Waldö, Maria, Nilsson, Christer, Blennow, Kaj, van Swieten, John C., Janelidze, Shorena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529985/
https://www.ncbi.nlm.nih.gov/pubmed/31139684
http://dx.doi.org/10.1002/acn3.763

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529985/
https://www.ncbi.nlm.nih.gov/pubmed/31139684
http://dx.doi.org/10.1002/acn3.763

Ejemplares similares